These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 33676247)

  • 21. Pharmaceutical grey water footprint: Accounting, influence of wastewater treatment plants and implications of the reuse.
    Martínez-Alcalá I; Pellicer-Martínez F; Fernández-López C
    Water Res; 2018 May; 135():278-287. PubMed ID: 29482095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence and removal of selected pharmaceuticals and personal care products in three wastewater-treatment plants.
    Kwon JW; Rodriguez JM
    Arch Environ Contam Toxicol; 2014 May; 66(4):538-48. PubMed ID: 24357097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review.
    Tran NH; Reinhard M; Gin KY
    Water Res; 2018 Apr; 133():182-207. PubMed ID: 29407700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'An investigation into the occurrence and removal of pharmaceuticals in Colombian wastewater'.
    Botero-Coy AM; Martínez-Pachón D; Boix C; Rincón RJ; Castillo N; Arias-Marín LP; Manrique-Losada L; Torres-Palma R; Moncayo-Lasso A; Hernández F
    Sci Total Environ; 2018 Nov; 642():842-853. PubMed ID: 30045524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total Release of 21 Indicator Pharmaceuticals Listed by the Swedish Medical Products Agency from Wastewater Treatment Plants to Surface Water Bodies in the 1.3 Million Populated County Skåne (Scania), Sweden.
    Björklund E; Svahn O
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence and removal of chemicals of emerging concern in wastewater treatment plants and their impact on receiving water systems.
    Golovko O; Örn S; Sörengård M; Frieberg K; Nassazzi W; Lai FY; Ahrens L
    Sci Total Environ; 2021 Feb; 754():142122. PubMed ID: 32920399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abundance, fate, and effects of pharmaceuticals and personal care products in aquatic environments.
    Adeleye AS; Xue J; Zhao Y; Taylor AA; Zenobio JE; Sun Y; Han Z; Salawu OA; Zhu Y
    J Hazard Mater; 2022 Feb; 424(Pt B):127284. PubMed ID: 34655870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of pharmaceuticals and personal care products (PPCPs) from wastewater: A review.
    Wang J; Wang S
    J Environ Manage; 2016 Nov; 182():620-640. PubMed ID: 27552641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of pharmaceutical residues, personal care products, lifestyle chemicals, illicit drugs and metabolites in wastewater and receiving surface waters of Krakow agglomeration in South Poland.
    Styszko K; Proctor K; Castrignanò E; Kasprzyk-Hordern B
    Sci Total Environ; 2021 May; 768():144360. PubMed ID: 33450690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wide-scope target screening characterization of legacy and emerging contaminants in the Danube River Basin by liquid and gas chromatography coupled with high-resolution mass spectrometry.
    Ng K; Alygizakis N; Nika MC; Galani A; Oswald P; Oswaldova M; Čirka Ľ; Kunkel U; Macherius A; Sengl M; Mariani G; Tavazzi S; Skejo H; Gawlik BM; Thomaidis NS; Slobodnik J
    Water Res; 2023 Feb; 230():119539. PubMed ID: 36610182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.
    Nguyen PY; Carvalho G; Reis MAM; Oehmen A
    Water Res; 2021 Jan; 188():116446. PubMed ID: 33038717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal efficiency for emerging contaminants in a WWTP from Madrid (Spain) after secondary and tertiary treatment and environmental impact on the Manzanares River.
    Lopez FJ; Pitarch E; Botero-Coy AM; Fabregat-Safont D; Ibáñez M; Marin JM; Peruga A; Ontañón N; Martínez-Morcillo S; Olalla A; Valcárcel Y; Varó I; Hernández F
    Sci Total Environ; 2022 Mar; 812():152567. PubMed ID: 34952067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Priority control sequence of 34 typical pollutants in effluents of Chinese wastewater treatment plants.
    He R; Wu X; Mu H; Chen L; Hu H; Wang J; Ren H; Wu B
    Water Res; 2023 Sep; 243():120338. PubMed ID: 37473511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring, mass balance and fate of pharmaceuticals and personal care products in seven wastewater treatment plants in Xiamen City, China.
    Wang Y; Li Y; Hu A; Rashid A; Ashfaq M; Wang Y; Wang H; Luo H; Yu CP; Sun Q
    J Hazard Mater; 2018 Jul; 354():81-90. PubMed ID: 29729602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A first screening and risk assessment of pharmaceuticals and additives in personal care products in waste water, sludge, recipient water and sediment from Faroe Islands, Iceland and Greenland.
    Huber S; Remberger M; Kaj L; Schlabach M; Jörundsdóttir HÓ; Vester J; Arnórsson M; Mortensen I; Schwartson R; Dam M
    Sci Total Environ; 2016 Aug; 562():13-25. PubMed ID: 27092417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of full-scale biological nutrient removal systems upgraded with physico-chemical processes for the removal of emerging pollutants present in wastewaters from Mexico.
    Estrada-Arriaga EB; Cortés-Muñoz JE; González-Herrera A; Calderón-Mólgora CG; de Lourdes Rivera-Huerta M; Ramírez-Camperos E; Montellano-Palacios L; Gelover-Santiago SL; Pérez-Castrejón S; Cardoso-Vigueros L; Martín-Domínguez A; García-Sánchez L
    Sci Total Environ; 2016 Nov; 571():1172-82. PubMed ID: 27457673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence, removal and mass loads of antiviral drugs in seven wastewater treatment plants with various treatment processes.
    Yao L; Chen ZY; Dou WY; Yao ZK; Duan XC; Chen ZF; Zhang LJ; Nong YJ; Zhao JL; Ying GG
    Water Res; 2021 Dec; 207():117803. PubMed ID: 34741900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution, mass load and environmental impact of multiple-class pharmaceuticals in conventional and upgraded municipal wastewater treatment plants in East China.
    Yuan X; Qiang Z; Ben W; Zhu B; Qu J
    Environ Sci Process Impacts; 2015 Mar; 17(3):596-605. PubMed ID: 25614232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.